There are 1076 resources available
96P - Liposomal irinotecan + 5-FU/LV + bevacizumab for second-line treatment of metastatic colorectal cancer (IRIS): A prospective, multi-center, single-arm clinical study
Presenter: Xuhua Hu
Session: Poster Display session
Resources:
Abstract
97P - Study on monitoring ripretinib and its metabolites plasma concentration in Chinese patients with gastrointestinal stromal tumors
Presenter: Hao Xu
Session: Poster Display session
Resources:
Abstract
98P - Real-world evidence on total neoadjuvant therapy (TNT) vs neoadjuvant concurrent chemoradiation (NA CCRT) for locally advanced rectal cancer (LARC) from a Tertiary Asian Cancer Centre
Presenter: Meng Wang
Session: Poster Display session
Resources:
Abstract
99P - Analysis of prognostic factors on trifluridine-tipiracil plus bevacizumab treatment in metastatic colorectal cancer: A retrospective real-world analysis
Presenter: Mai Onishi
Session: Poster Display session
Resources:
Abstract
100P - Treatment outcomes in rectal cancer with radiological positive circumferential resection margin treated with short course radiation therapy
Presenter: Shaifali Mahajan
Session: Poster Display session
Resources:
Abstract
101P - A1Check: External validation of an intraoperative machine learning model predicting colorectal anastomotic leakage
Presenter: Sara Ben Hmido
Session: Poster Display session
Resources:
Abstract
102P - Impact of primary tumor sidedness on survival outcomes in early-onset and late-onset colorectal cancer
Presenter: Mohammed Al Habsi
Session: Poster Display session
Resources:
Abstract
103P - Characteristics of colon cancer in the comprehensive cancer center and overall survival of young versus old patients: Single institute experience from 2015 -2021
Presenter: Hosam Alghanmi
Session: Poster Display session
Resources:
Abstract
104P - Clinical observation and immune effects of high-intensity focused ultrasound (HIFU) in the treatment of liver metastasis in colorectal cancer
Presenter: Shasha Wang
Session: Poster Display session
Resources:
Abstract
105P - TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice
Presenter: Ji Eun Shin
Session: Poster Display session
Resources:
Abstract